Clinical Trial Update: Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating denosumab on bone and vascular metabolism in osteoporotic chronic kidney disease; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Female With Osteoporosis and Chronic Kidney Disease | Phase 4 | Status: TERMINATED